Translational Medicine

Translational Medicine
Open Access

ISSN: 2161-1025

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Aims and Scope

Translational Medicine is a broad-based journal found on two key tenets: To publish the most exciting reviews on Translational Medicine: Second to provide  a rapid and  quick reviewing and publishing of articles for research, teaching and reference purposes.

The Journal seeks high-quality submissions and welcome contributions in molecular-diagnostics, personalized-medicine, translational-medicine, discovering-novel-biomarkers, drug-delivery-and-nanoparticle, translational-research-for-cardiovascular-diseases, biomedical-research, translational-regenerative-medicine, molecular-targeted-therapies, molecular-signalling-and-apoptosis

Translational Medicine-Open Access gives a world wide audience larger than that of any subscription-based journal in Longdom field, no matter how prestigious or popular, and probably increases the visibility and impact of published work. Translational Medicine-Open Access gives barrier-free access to the literature for research. It increases convenience, reach, and retrieval power. Free online literature is available for software that facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis. Translational Medicine-Open Access puts rich and poor on an equal footing for these key resources and eliminates the need for permissions to reproduce and distribute content.

Longdom Group is ardent to Open Access. We strongly believe that removing barriers to research published online will greatly aid to the progress in Longdom scientific and technical disciplines.

All published articles will be assigned DOI provided by CrossRef. Translational Medicine will keep upto date with latest advances in the field and papers published in Translational Medicine will reach the readers directly by email for free of cost.

Distributed widely through the Internet.

Archived online in the transactions of the Longdom Publishing, which provides the international scientific community with immediate and permanent access to individual papers.

Translational Medicine accepts online letters to the editors, brief comments that contributes to the previously published articles or other relevant findings in Longdom field.

Open Access is a publication model, that enables the dissemination of research articles to the global community without restriction usually through the internet. Thus, all articles published under Open Access can be accessed by anyone with internet connection. Translational Medicine strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Translational Medicine are freely accessible to everyone immediately after publication.

All works published by the Longdom Publishing are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adopt the work provided, the original work and source is appropriately cited. TM strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. The journal keeps updated reviews on Translational Medicine. Abstracts and full texts (HTML, PDF and XML format) of all articles published by this journal are freely accessible to everyone immediately after publication. TM supports the Bethesda Statement on Open Access Publishing

Definition of Open Access Publication

An Open Access Publication is one that meets the following two conditions:

  • The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.

  • A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable Open Access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).

As a member of Publisher International linking Association, PILA, Translational Medicine (of Longdom Publishing Group) follows the Creative Commons Attribution License and Scholars Open Access publishing policies.

Note:

Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.

Top